Treatment of chronic cough, breathlessness and dyspnea
US11660296B2 · kind B2 · utility
1Cited by
23References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 24, 2022 |
| Grant date | May 30, 2023 |
| Priority date | — |
| Expiry date | Mar 24, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.